Quantcast

Latest central nervous system disease Stories

2014-04-22 10:44:59

Researchers at the University of Toronto say a sleep disorder that causes people to act out their dreams is the best current predictor of brain diseases like Parkinson's and Alzheimer's. "Rapid-eye-movement sleep behavior disorder (RBD) is not just a precursor but also a critical warning sign of neurodegeneration that can lead to brain disease," says associate professor and lead author Dr. John Peever. In fact, as many as 80 to 90 per cent of people with RBD will develop a brain disease."...

2013-07-23 13:26:22

In degenerative brain diseases and after stroke, nerve cells die while their support cells activate the brain's immune system to cause further damage. Now Jonathan Gilthorpe, Adrian Pini and Andrew Lumsden at the MRC Centre for Developmental Neurobiology at King's College London, have found that a single protein, histone H1, causes these distinct outcomes. The research passed peer review within a week of being published in F1000Research, where Jan-Marino Ramirez, of the University of...

2013-04-25 15:50:31

Discovery widens treatment options for neurodegenerative and central nervous system disease Neurodegenerative and central nervous system (CNS) diseases represent a major public health issue affecting at least 20 million children and adults in the United States alone. Multiple drugs exist to treat and potentially cure these debilitating diseases, but 98 percent of all potential pharmaceutical agents are prevented from reaching the CNS directly due to the blood-brain barrier. Using...

2011-10-28 12:15:05

Italian and Spanish scientists studying the use of stem cells for treating spinal cord injuries have provided the first evidence to show that meninges, the membrane which envelops the central nervous system, is a potential source of self-renewing stem cells. The research, published in STEM CELLS, develops the understanding of cell activation in central nervous system injuries; advancing research into new treatments for spinal injuries and degenerative brain disorders. The team focused...

2011-10-28 04:00:00

Italian and Spanish scientists studying the use of stem cells for treating spinal cord injuries have provided the first evidence to show that meninges, the membrane which envelops the central nervous system, is a potential source of self-renewing stem cells. The research, published in STEM CELLS, develops the understanding of cell activation in central nervous system injuries; advancing research into new treatments for spinal injuries and degenerative brain disorders. Durham, NC (PRWEB)...

2011-04-20 12:05:00

ROCKVILLE, Md., April 20, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced it has signed a Memorandum of Understanding with BaYi Brain Hospital in Beijing, China. Under the agreement, BaYi Brain and Neuralstem will jointly prepare a clinical protocol for treatment of motor deficits due to ischemic stroke. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) BaYi Brain will prepare the Mandarin version of the clinical trial documents and submit the documents to...

2011-03-03 07:10:00

ROCKVILLE, Md., March 3, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) today announced that CEO and President Richard Garr is scheduled to present at the Cowen and Company 31st Annual Health Care Conference on Monday, March 7 at 4:45p.m. EST at the Boston Marriott Copley Place in Boston. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO) Mr. Garr is expected to present an overview and update the progress of Neuralstem's Phase I clinical trial of its spinal cord stem...

2011-03-01 06:00:00

ROCKVILLE, Md., March 1, 2011 /PRNewswire/ -- Neuralstem, Inc. (Amex: CUR) announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single...

2011-02-09 11:56:00

ROCKVILLE, Md., Feb. 9, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS) with its human spinal cord derived neural stem cells (NSI-566RSC), currently in a Phase I safety study to evaluate the safety of the product and the surgical route of administration in a wide range of ALS patients. (Logo:...


Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related